MRI allows for earlier detection of the joint synovitis, erosions, and bone marrow edema present in inflammatory arthritis, facilitating earlier diagnosis and treatment… Read More
Recent advances in drug therapies for rheumatoid arthritis (RA) have increased the importance of early intervention. Several serological testing and imaging techniques help facilitate early diagnosis… Read More
A 65-year-old woman, who was confined to a wheelchair because of severe rheumatoid arthritis, was concerned about nodules that had erupted on her fingers and hands during the previous 3 weeks… Read More
A 50 year-old physician experienced the abrupt onset of tenderness and swelling in the distal interphalangeal (DIP) joint of his right index finger. His only significant past medical history was Wolf-Parkinson-White syndrome… Read More
Lack of conviction and motivation, not pain or depression, appear to be the major factors that deter nearly half of RA patients from moving about enough to ease their symptoms. Chicago researchers suggest what should be done about this.
New CDC data indicate that persons who have arthritis are significantly more likely to be physically inactive than those who do not, in spite of the proven benefits of physical activity for arthritis management.
Although the terms "exercise" and "heart health" are practically synonymous, members of The International Society of Exercise and Immunology (ISEI) are accustomed to looking at the effects of exercise on a deeper level.
In patients with rheumatoid arthritis (RA), radiographic progression with nonbiologic treatment is minimal only when those in 28-joint Disease Activity Score (DAS 28) remission have no persistent residual joint swelling.
A potential way to halt the cartilage destruction that occurs with rheumatoid arthritis (RA) without suppressing the immune system has been identified by a new study supported by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS).
Rheumatoid arthritis (RA) is a progressive immune-mediated disease involving the synovium that can culminate in joint destruction, significant functional impairment, and early mortality.
Persons as young as 45 to 64 years will account for more than half of new diagnoses of knee osteoarthritis over the next decade. A vaccine designed to reeducate the immune system is safe and feasible in treating patients with RA. Vitamin D supplementation plays a beneficial role in patients with lupus.
Lack of conviction and motivation, not pain or depression, appear to be the major factors that deter nearly half of RA patients from moving about enough to ease their symptoms. Chicago researchers suggest what should be done about this. More »
In patients with rheumatoid arthritis (RA), radiographic progression with nonbiologic treatment is minimal only when those in 28-joint Disease Activity Score (DAS 28) remission have no persistent residual joint swelling. More »
Concise report. Undifferentiated arthritis characteristics and outcomes when applying the 2010 and 1987 criteria for rheumatoidarthritis. ... Accepted 12 August 2011. Published Online First 27 September 2011. Objective Undifferentiated arthritis ( UA)
The induction of antinuclear antibodies (ANA) or anti-double stranded (ds) -DNA antibodies (Abs) after infliximab (IFX) therapy in rheumatoidarthritis (RA) is a well-known phenomenon, but the correlation of such Abs with the clinical response to IFX has not yet been determined. The aims of this retrospective observational study were to examine the prevalence of positive ANA and anti-ds-DNA Abs before and after IFX therapy in patients with RA and to investigate whether an increased titer of such Abs is a
This study aimed to establish the profile and the evolution of an early Rheumatoidarthritis (RA) cohort in the Moroccan population and also to search possible predictor factors of structural progression.|This study aimed to establish the profile and the evolution of an early Rheumatoidarthritis (RA) cohort in the Moroccan population and also to search possible predictor factors of structural progression.
To compare the efficacy in terms of Health Assessment Questionnaire change from baseline (HAQ CFB), 50% improvement in American College of Rheumatology criterion (ACR-50) and DAS28 defined remission (<2.6) between abatacept and other biologic disease modifying anti-rheumatic drugs (DMARDs) in patients with rheumatoidarthritis (RA) who have inadequate response to methotrexate (MTX-IR).|To compare the efficacy in terms of Health Assessment Questionnaire change from baseline (HAQ CFB), 50% improvement in Ame
Tax Schemes Every Physician Should Avoid Ike Devji, JD, January 31, 2012 The next 60 days marks the final push to sell physicians across the United States tax plans of both good and questionable value.
Prevent Physician Distraction When Using mHealth Technology Aubrey Westgate, January 25, 2012 As more and more physicians use handheld mobile technology in their day-to-day work, some critics are raising concerns about “distracted doctoring.”
Can That Applicant Do the Job at Your Medical Practice? Karen Zupko, January 25, 2012 If like many communities, yours has significant numbers of non-English speaking people with whom neither you nor your staff are able to converse, your practice is at a serious disadvantage.
The armamentarium of treatment modalities available to physicians seeing patients with rheumatoid arthritis (RA) and other forms of inflammatory arthritis has increased dramatically in recent years. In particular, the introduction of the biologic disease-modifying antirheumatic drugs (DMARDs), most notably the tumor necrosis factor a (TNF-a) inhibitors, has afforded clinicians new opportunities to mitigate disease progression.
Rheumatoid arthritis (RA) often presents late, when irreversible damage has occurred. More than half of primary care consultations are for joint pain, but the average time from initial presentation with symptoms to confirmation of diagnosis of RA is 18 weeks.
